Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | FNTA | P49354 | 1/20 | 0.36 |
| ▸ | FNTB | P49356 | 1/20 | 0.36 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5152482 | 1.00 | ALDH1A1 (0.47) | ALDH1A1ALOX15TRPV1NAAAPTPN1 | |
| SCHEMBL21518285 | 0.86 | ALDH1A1 (0.46) | ALDH1A1ALOX15TRPV1NAAAPTPN1 | |
| SCHEMBL21518310 | 0.86 | ALDH1A1 (0.46) | ALDH1A1ALOX15TRPV1NAAAPTPN1 | |
| SCHEMBL3659692 | 0.85 | ALDH1A1 (0.42) | ALDH1A1ALOX15TRPV1NAAAPTPN1 | |
| SCHEMBL11694292 | 0.84 | ALDH1A1 (0.48) | ALDH1A1ALOX15TRPV1PTPN1TSHR | |
| SCHEMBL11694288 | 0.84 | ALDH1A1 (0.48) | ALDH1A1ALOX15TRPV1PTPN1TSHR | |
| SCHEMBL3169676 | 0.83 | ALDH1A1 (0.66) | ALDH1A1ALOX15TRPV1PTPN1FNTA | |
| SCHEMBL9953013 | 0.83 | ALDH1A1 (0.66) | ALDH1A1ALOX15TRPV1PTPN1FNTA | |
| SCHEMBL3169682 | 0.83 | ALDH1A1 (0.66) | ALDH1A1ALOX15TRPV1PTPN1FNTA | |
| SCHEMBL1532465 | 0.83 | ALDH1A1 (0.71) | ALDH1A1ALOX15TRPV1FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1188433-B1 | Use of unsaturated esters as perfuming ingredients | FIRMENICH & CIE (CH) | 2007-01-03 | — | — | EP | claimed |
| US-6924262-B2 | Use of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2005-08-02 | — | — | US | claimed |
| US-20020055455-A1 | Use of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2002-05-09 | — | — | US | claimed |
| EP-1188433-A2 | Use of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2002-03-20 | — | — | EP | claimed |
| EP-1188433-B1 | Use of unsaturated esters as perfuming ingredients | FIRMENICH & CIE (CH) | 2007-01-03 | — | — | EP | disclosed |
| US-6924262-B2 | Use of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2005-08-02 | — | — | US | disclosed |
| US-20020055455-A1 | Use of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2002-05-09 | — | — | US | disclosed |
| EP-1188433-A2 | Use of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2002-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020055455-A1 | Use of unsaturated esters as perfuming ingredients | CYP2E1, ELOVL1, ELOVL5 | ALDH1A1 744/4885ALOX15 21/4885TRPV1 348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.